Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Anemia, Refractory, with Excess of Blasts 10Myelodysplastic Syndromes 8Leukemia 7Leukemia, Myelomonocytic, Chronic 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 5Leukemia, Myeloid, Acute 5Anemia, Refractory 5Myeloproliferative Disorders 4Myelodysplastic-Myeloproliferative Diseases 3Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3Anemia 3Thrombocytopenia 2Neutropenia 2Neoplasms 2Lymphoma, Non-Hodgkin 2Leukemia, Myelomonocytic, Juvenile 2Hodgkin Disease 2Congenital Abnormalities 2Anemia, Sickle Cell 2Anemia, Aplastic 2Wilms Tumor 1Uveal Melanoma 1Uterine Cervical Neoplasms 1Tourette Syndrome 1Testicular Neoplasms 1Stress Disorders, Post-Traumatic 1Squamous Cell Carcinoma of Head and Neck 1Sleep Initiation and Maintenance Disorders 1Severe Acute Respiratory Syndrome 1Seizures 1

Interventions

Medical Marijuana 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Tourette Syndrome × Classical hematology × Clear all
NCT03944447 2022-06-02

OMNI-Can

OMNI Medical Services, LLC

Phase 2 Unknown
200,000 enrolled
Classical hematology

Chronic Traumatic Encephalopathy, Brain Injuries, Traumatic, COVID-19, Acquired Immunodeficiency Syndrome, Amyotrophic Lateral Sclerosis, Anemia, Sickle Cell, Anxiety Disorders, Autistic Disorder, Bipolar Disorder, Colitis, Ulcerative, Crohn Disease, Depression, Epilepsy, Fibromyalgia, Tourette Syndrome, Glaucoma, Hepatitis C, Sleep Initiation and Maintenance Disorders, Multiple Sclerosis, Opioid-Related Disorders, Neoplasms, Parkinson Disease, Seizures, Stress Disorders, Post-Traumatic, Inflammatory Bowel Diseases, Coronavirus Infections, Severe Acute Respiratory Syndrome, Chronic Pain

Data powered by HemOnc (CC BY 4.0) Colophon âš¡